Estrogen/NN
receptor/NN
concentration/NN
and/CC
social/JJ
factors/NNS
as/IN
predictors/NNS
of/IN
natural/JJ
killer/NN
cell/NN
activity/NN
in/IN
early-stage/JJ
breast/NN
cancer/NN
patients/NNS
./.
=====
Confirmation/NN
of/IN
a/DT
model/NN
./.

Previous/JJ
work/NN
of/IN
ours/PP
has/VBZ
demonstrated/VBN
that/IN
a/DT
significant/JJ
amount/NN
of/IN
natural/JJ
killer/NN
(/(
NK/NN
)/)
activity/NN
variance/NN
after/IN
surgery/NN
in/IN
stage/NN
I/CD
and/CC
II/CD
breast/NN
cancer/NN
patients/NNS
could/MD
be/VB
accounted/VBN
for/IN
by/IN
both/CC
the/DT
estrogen/NN
receptor/NN
(/(
ER/NN
)/)
status/NN
of/IN
the/DT
tumor/NN
and/CC
by/IN
social/JJ
factors/NNS
,/,
namely/RB
,/,
perceived/VBN
social/JJ
support/NN
and/CC
seeking/VBG
social/JJ
support/NN
as/IN
a/DT
general/JJ
coping/NN
strategy/NN
./.
=====
As/IN
considerable/JJ
evidence/NN
has/VBZ
accumulated/VBN
that/IN
social/JJ
support/NN
in/IN
both/CC
animal/NN
and/CC
human/JJ
populations/NNS
may/MD
have/VB
survival/NN
value/NN
,/,
we/PRP
sought/VBD
to/TO
test/VB
the/DT
reliability/NN
of/IN
this/DT
regression/NN
model/NN
,/,
using/VBG
coping/NN
and/CC
perceived/VBN
support/NN
factor/NN
values/NNS
obtained/VBN
at/IN
3/CD
months/NNS
after/IN
surgery/NN
to/TO
account/VB
for/IN
concurrent/JJ
follow-up/JJ
NK/NN
activity/NN
in/IN
this/DT
serially/RB
assessed/VBN
group/NN
of/IN
patients/NNS
./.
=====
It/PRP
was/VBD
found/VBN
that/IN
the/DT
most/RBS
significant/JJ
variable/NN
predicting/VBG
NK/NN
activity/NN
at/IN
follow-up/NN
was/VBD
tumor/NN
ER/NN
concentration/NN
,/,
with/IN
higher/JJR
NK/NN
activity/NN
associated/VBN
with/IN
ER-/JJ
status/NN
./.
=====
In/IN
addition/NN
,/,
seeking/VBG
social/JJ
support/NN
as/IN
a/DT
coping/NN
strategy/NN
,/,
as/RB
well/RB
as/IN
the/DT
perceived/VBN
quality/NN
of/IN
support/NN
,/,
also/RB
entered/VBD
the/DT
model/NN
to/TO
account/VB
for/IN
a/DT
significant/JJ
amount/NN
of/IN
NK/NN
activity/NN
variance/NN
(/(
multivariate/JJ
F/NN
=/JJ
5.25/CD
,/,
p/NN
less/JJR
than/IN
0.001/CD
)/)
./.
=====
If/IN
,/,
as/IN
the/DT
literature/NN
suggests/VBZ
,/,
NK/NN
activity/NN
is/VBZ
relevant/JJ
to/TO
breast/NN
cancer/NN
control/NN
,/,
and/CC
since/IN
ER-/NN
tumors/NNS
have/VBP
a/DT
worse/JJR
prognosis/NN
,/,
we/PRP
suggest/VBP
here/RB
that/IN
perhaps/RB
such/JJ
tumors/NNS
are/VBP
resistant/JJ
to/TO
control/NN
by/IN
NK/NN
cells/NNS
because/IN
they/PRP
lack/VBP
the/DT
ability/NN
to/TO
attract/VB
an/DT
accumulation/NN
of/IN
effector/NN
cells/NNS
to/TO
the/DT
tumor/NN
site/NN
,/,
or/CC
because/IN
blocking/NN
factors/NNS
at/IN
the/DT
site/NN
of/IN
the/DT
tumor/NN
prevent/VBP
local/JJ
tumor/NN
control/NN
at/IN
the/DT
site/NN
of/IN
action/NN
./.
=====
The/DT
finding/NN
related/JJ
to/TO
social/JJ
support/NN
also/RB
replicates/VBZ
results/NNS
from/IN
an/DT
independent/JJ
sample/NN
of/IN
breast/NN
cancer/NN
patients/NNS
./.
=====
This/DT
finding/NN
,/,
taken/VBN
together/RB
with/IN
other/JJ
evidence/NN
that/IN
this/DT
social/JJ
variable/NN
is/VBZ
associated/VBN
with/IN
longer/JJR
survival/NN
in/IN
breast/NN
cancer/NN
populations/NNS
,/,
underscores/VBZ
the/DT
potential/JJ
importance/NN
of/IN
this/DT
social/JJ
support/NN
variable/NN
./.
=====
Our/PRP$
findings/NNS
also/RB
suggest/VBP
one/CD
possible/JJ
immunological/JJ
variable/NN
involved/JJ
,/,
with/IN
potential/JJ
clinical/JJ
significance/NN
,/,
for/IN
this/DT
patient/NN
population/NN
./.